Why Optimism And Resilience Are Non-Negotiable In Biotech Entrepreneurship with Brad Niles, CEO of ARIZ Precision Medicine
Combining a lifelong passion for science and business with personal experiences can fuel groundbreaking innovations in cancer therapy.
In this episode, Brad Niles, CEO of ARIZ Precision Medicine, shares his entrepreneurial journey, from quirky early ventures like breeding mice and wedding pigeons to co-founding a biotech company. Motivated by a personal connection to cancer, he discusses ARIZ’s development of siRNA-based therapies targeting genetic drivers like the Prdm2 gene in lung cancer, aiming for precision treatment with fewer side effects. Brad reflects on the challenges of biotech entrepreneurship, including securing funding, building expert networks, and working within regional innovation ecosystems. He also explores regulatory shifts, drug pricing complexities, and how environmental and demographic changes are reshaping cancer trends.
Tune in to explore the journey from early ventures to cutting-edge cancer therapies, and discover the power of resilience, networking, and precision medicine in shaping the future of cancer care!
Resources:
Connect with and follow Brad Niles on LinkedIn.
Follow ARIZ on their LinkedIn and visit their website.
Email Brad directly here.
--------
57:22
The Secrets Of Nitric Oxide in Disease Prevention with Dr. Nathan Bryan, Founder and CEO of Bryan Therapeutics
Nitric oxide is crucial for oxygen delivery and blood vessel relaxation, impacting overall health.
In this episode, Dr. Nathan Bryan discusses the role and therapeutic potential of nitric oxide and the challenges in its therapy development, explaining how chronic diseases can stem from missing molecules or toxins and how to naturally restore nitric oxide production. Dr. Bryan also shares insights on nitric oxide’s benefits in treating conditions like ischemic heart disease, Alzheimer's, and diabetic ulcers, emphasizing the importance of understanding its correct dosage.
Tune in and learn how nitric oxide can transform health and therapeutic approaches for chronic diseases!
--------
47:54
The Shift Towards Point-of-Care Diagnostics with Glenn Snyder, Principal and Global MedTech Practice Leader at Monitor Deloitte
The future of healthcare lies in emerging opportunities in point-of-care diagnostics and retail healthcare settings.
In this episode, Glenn Snyder delves into the distinctions between operational and strategy consulting, emphasizing the crucial role of strategy in directing business operations. He highlights the significance of alignment in the MedTech industry, particularly in adapting to the evolving landscape shaped by technological advancements.
Tune in and learn how to adapt and thrive in the ever-evolving MedTech world and discover why strategy is crucial in directing business operations.
--------
40:59
The Key to Entrepreneurial Success in Healthcare with Dr. Ankit Agarwal, CEO and Co-Founder of Imbed Biosciences
Market validation is crucial for aspiring entrepreneurs, particularly in solving unmet clinical needs.
In this episode, Dr. Ankit Agarwal, CEO and co-founder of Imbed Biosciences, shares his journey from engineering to business, highlighting the role of the Kauffman Fellowship program in his entrepreneurial success. He discusses the importance of timing, market validation, and solving unmet clinical needs for aspiring entrepreneurs, while also showcasing his innovative work in developing synthetic wound matrix technology for chronic ulcers.
Tune in and learn how Dr. Ankit Agarwal’s journey can inspire your own entrepreneurial endeavors in science and technology-based startups!
--------
35:59
Exploring the Vital Role of 340B Program in Healthcare Affordability with Paul Leschiner, Senior National Account Manager for Optum Health
Trust is the cornerstone of successful business relationships.
In this episode, Paul Leschiner discusses the 340B program and healthcare technology, emphasizing its critical role in reducing medication costs for low-income patients. He explores challenges within the 340B space, such as legal battles and sustainability concerns, while stressing the significance of patient-focused pricing and trust in business relationships, alongside personal strategies for building trust and advocating for healthcare equity through awareness of programs like 340B.
Tune in and learn how patient-focused pricing ensures equitable access to healthcare services and medications!
The HealthTech Invest podcast will help you be in the know on all things Healthcare Investing. Through interviews with cutting-edge health entrepreneurs, savvy investors, health system leaders, and more, the HealthTech Invest podcast powered by Niterra, will help you level up and make an impact in healthcare investing.
Polska